Create Free Account

By creating account you will get access to hot stocks & personalised emails

Oncosil Medical Ltd

Healthcare AU OSL

0.005AUD
-(-%)

Last update at 2024-05-01T01:00:00Z

Day Range

0.0050.005
LowHigh

52 Week Range

0.0040.01
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -11.34293M -10.72670M -10.43352M -4.26189M -8.56673M
Minority interest - - - - -
Net income -11.34293M -10.72670M -10.43352M -4.26189M -4.68307M
Selling general administrative 6.56M 6.80M 5.97M 1.70M 5.62M
Selling and marketing expenses 0.13M 0.37M 0.68M 0.68M -
Gross profit -1.22110M -0.74069M -0.74795M -0.74795M 3.63M
Reconciled depreciation 0.18M 0.13M 0.18M 0.15M 0.04M
Ebit -11.34292M -11.53623M -10.43244M -4.26103M -12.45039M
Ebitda -11.16703M -11.40932M -10.24766M -4.11175M -12.41178M
Depreciation and amortization 0.18M 0.13M 0.18M 0.15M 0.04M
Non operating income net other - - - - -
Operating income -11.33549M -10.57772M -10.54189M -4.26103M -12.45039M
Other operating expenses 9.68M 9.84M 9.88M 7.36M 12.45M
Interest expense 0.00001M 0.00949M 0.00108M 0.00086M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.07M 0.01M 0.08M 0.01000M 0.01M
Net interest income 0.05M -0.00949M 0.08M -0.00086M 0.20M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.16M -0.11742M 1.13M 2.85M -3.88366M
Total revenue 0.37M 0.23M 0.21M 0.21M 3.83M
Total operating expenses 11.51M 10.80M 11.06M 7.36M 12.45M
Cost of revenue 1.59M 0.97M 0.96M 0.96M -
Total other income expense net 1.16M 0.69M 1.13M 2.85M 3.88M
Discontinued operations - - - - -
Net income from continuing ops -11.34293M -10.72670M -10.43352M -4.26189M -8.56673M
Net income applicable to common shares -11.34293M -10.72670M -10.43352M -4.26189M -8.56673M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 11.47M 13.07M 14.15M 24.06M 11.67M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.12M 0.47M 0.11M 0.07M 0.07M
Total liab 1.59M 1.91M 2.45M 2.16M 0.99M
Total stockholder equity 9.88M 11.16M 11.70M 21.90M 10.68M
Deferred long term liab - - - - -
Other current liab 0.61M 0.84M 0.91M 0.80M 0.63M
Common stock 86.51M 79.91M 70.40M 70.14M 52.26M
Capital stock 86.51M 79.91M 70.40M 70.14M 52.26M
Retained earnings -84.36754M -73.02461M -62.29791M -51.86438M -47.60249M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 9.39M 11.28M 12.24M 21.00M 7.69M
Cash and equivalents - - - - 7.69M
Total current liabilities 1.57M 1.77M 2.13M 2.16M 0.99M
Current deferred revenue -0.14625M -0.16537M -0.16324M -0.10994M -0.10994M
Net debt -9.22302M -10.97563M -11.75547M -20.88804M -7.57929M
Short term debt 0.15M 0.17M 0.16M 0.11M 0.11M
Short long term debt - - - 0.03M -
Short long term debt total 0.17M 0.30M 0.48M 0.11M 0.11M
Other stockholder equity -2.13979M -6.88512M -8.09941M -18.27293M 6.02M
Property plant equipment 0.24M 0.32M 0.53M 0.14M 0.06M
Total current assets 11.23M 12.74M 13.62M 23.92M 11.61M
Long term investments - - - - -
Net tangible assets 9.88M 11.16M 11.70M 21.90M 10.68M
Short term investments 0.12M 0.09M 0.09M 0.07M 0.07M
Net receivables 1.29M 0.91M 1.18M 2.81M 3.82M
Long term debt - - - - -
Inventory - - - -0.02067M -0.04083M
Accounts payable 0.96M 0.93M 1.23M 1.36M 0.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.74M 4.28M 3.60M 3.63M 6.02M
Additional paid in capital - - - - -
Common stock total equity - - - 70.14M 52.26M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -0.23926M -0.32493M -0.53078M -0.13837M 0.06M
Deferred long term asset charges - - - - -
Non current assets total 0.24M 0.32M 0.53M 0.14M 0.06M
Capital lease obligations 0.17M 0.30M 0.48M 0.08M -
Long term debt total 0.02M 0.14M 0.32M 0.00000M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.05782M -0.00583M -0.05400M -0.02072M -0.01483M
Change to liabilities -0.07853M -0.07431M -0.04932M 1.01M -0.81644M
Total cashflows from investing activities -0.05782M -0.00583M -0.05400M -0.02072M -0.01483M
Net borrowings -0.18721M -0.16023M -0.14875M -0.09453M -0.09453M
Total cash from financing activities 9.49M 9.16M 0.11M 17.79M 17.79M
Change to operating activities -0.07517M -0.45532M 1.54M 1.04M 0.76M
Net income -11.34293M -10.72670M -10.43352M -4.26189M -8.56673M
Change in cash -1.88601M -0.96000M -8.75815M 13.31M -7.51598M
Begin period cash flow 11.28M 12.24M 21.00M 7.69M 15.21M
End period cash flow 9.39M 11.28M 12.24M 21.00M 7.69M
Total cash from operating activities -11.31563M -10.11018M -8.81540M -4.45608M -7.50115M
Issuance of capital stock 9.67M 9.32M 0.26M 19.10M -
Depreciation 0.18M 0.19M 0.18M 0.15M 0.04M
Other cashflows from investing activities - - - - -
Dividends paid - - - 0.03M -
Change to inventory - - - - -
Change to account receivables -0.37794M 0.27M -0.02869M -0.02869M -0.02869M
Sale purchase of stock 9.67M 9.32M 0.26M -1.21965M -1.21965M
Other cashflows from financing activities -0.18721M -0.16023M -0.12218M -0.09453M -0.09453M
Change to netincome 0.38M 0.68M -0.03137M -2.39202M 1.09M
Capital expenditures 0.06M 0.00583M 0.05M 0.02M 0.01M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.37794M 0.27M -0.02869M 3.91M 4.49M
Stock based compensation 0.39M 0.59M -0.14080M -2.39088M -
Other non cash items -0.14860M 0.42M 1.43M 2.05M 8.53M
Free cash flow -11.37345M -10.11601M -8.86940M -4.47680M -0.01483M

Fundamentals

  • Previous Close 0.005
  • Market Cap11.28M
  • Volume7607746
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-11.63866M
  • Revenue TTM1.30M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM -0.12135M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OSL
Oncosil Medical Ltd		 - -% 0.005 - - 8.68 3.31 36.56 -0.7158
COH
Cochlear Ltd		 -8.06 2.48% 317.04 60.87 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd		 -0.035 1.71% 2.02 - 140.85 17.37 21.49 17.51 647.42
AVR
Anteris Technologies Ltd		 -0.21 0.96% 21.69 - - 104.23 14.98 95.15 -5.9152
AVH
Avita Therapeutics Inc		 -0.05 1.86% 2.64 - - 8.59 5.71 6.72 -10.0538

Reports Covered

Stock Research & News

View All

Profile

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Oncosil Medical Ltd

7 Eden Park Drive, Macquarie Park, NSW, Australia, 2113

Key Executives

Name Title Year Born
Mr. Nigel Lange CEO, MD & Director NA
Mr. Karl David Pechmann CFO & Company Sec. NA
Mr. Michael Warrener Global Sales & Marketing Director NA
Dr. David Charles James Global Head of Manufacturing Operations NA
Dr. Ralph Peters Chief Medical Officer NA
Mr. David Turner Head of Medical Affairs NA
Mr. Christian Dal Cin CFO & Company Secretary NA
Mr. Christian Dal Cin CFO & Company Secretary NA
Mr. Christian Dal Cin CFO & Company Secretary NA
Mr. Christian Dal Cin CFO & Company Secretary NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.